The HDO Health 'Journiquet': A Novel Device to Stop Junctional Bleeding Quickly and Effectively

Bleeding to death is the leading cause of preventable fatalities, including 90% of combat and 40% of civilian fatalities. Nearly 20% of these deaths are due to uncontrolled bleeding at the torso-appendage junction. Specialized junctional tourniquets in this market require professional training, time-consuming multi-step assembly, fine- motor movements, and users experience a high rate of device displacement during patient transport.

The HDO Health Journiquet™ is a novel, class II, non-sterile, non- invasive, single-use medical device designed to stop junctional bleeding quickly and effectively. It can be rapidly deployed (estimated at 20 seconds) in high-stress combat and trauma environments. Application requires only gross motor movements, even when wearing tactical or medical gloves and in wet environments, enabling hemorrhage control while the patient is still in the field. The Journiquet™ has a user-driven and intuitive design, requiring little-to- no training by a novice user. It is durable, and pre-assembled as a single device with a compact design optimized for tactical stowage and quick deployment in harsh operating conditions. It allows direct pressure on the wound while remaining in place during patient transport 

Join us at the March Inventor Showcase on Tuesday, May 9 at 12 noon to learn more about the team and their innovative product. 

Welcome Address: Dr. Cynthia Gerhardt, Chief Clinical Research Officer, Nationwide Children's Hospital 

More Information About HDO health

 More Information About the Event